Operating income decreased 76.3%
Operating income changed -76.3% from the comparable as-filed period.
-$4.9M→-$8.7M1 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CTOR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development decreased 76.7%
Research & development changed -76.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$938,277→$218,4962 prior comparisons
Stock-based compensation increased 67.5%
Stock-based compensation changed +67.5% from the comparable as-filed period.
$2.1M→$3.6M2 prior comparisons
Inventory increased 31.5%
Inventory changed +31.5% from the comparable as-filed period.
$17.2M→$22.6M2 prior comparisons
Current assets increased 133.3%
Current assets changed +133.3% from the comparable as-filed period.
$18.3M→$42.7M3 prior comparisons
Working capital increased 53.6%
Working capital changed +53.6% from the comparable as-filed period.
-$34.7M→-$16.1M3 prior comparisons
Total assets increased 22.2%
Total assets changed +22.2% from the comparable as-filed period.
$91.7M→$112.1M3 prior comparisons
Current ratio increased 110.3%
Current ratio changed +110.3% from the comparable as-filed period.
0.35→0.733 prior comparisons
Working capital / assets moved 2347 bp higher
Working capital / assets changed +2347 basis points from the comparable as-filed period.
-37.82%→-14.35%3 prior comparisons
Shares outstanding increased 18.6%
Shares outstanding changed +18.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
78,370,584→92,981,2044 prior comparisons
Cash & equivalents changed across a low base
Cash & equivalents changed +14788922.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$112→$16.6M1 prior comparisons
Current liabilities increased 10.9%
Current liabilities changed +10.9% from the comparable as-filed period.
$53.0M→$58.8M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.